WASP: A key immunological multitasker

Nature Reviews Immunology

Volumn 10, Issue 3, 2010, Pages 182-192

  Thrasher, Adrian J ^a   Burns, Siobhan O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEURAL WISKOTT ALDRICH SYNDROME PROTEIN;

AUTOIMMUNITY; GENE MUTATION; HEMATOPOIESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

ANIMALS; HUMANS; IMMUNITY, INNATE; NEUTROPENIA; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 77649153819     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2724     Document Type: Review

References (102)

1. Takenawa, T. & Suetsugu, S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nature Rev. Mol. Cell Biol. 8, 37-48 (2007).
2. Kurisu, S. & Takenawa, T. The WASP and WAVE family proteins. Genome Biol. 10, 226 (2009).
3. Symons, M. et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell 84, 723-734 (1996).
4. Rohatgi, R. et al. The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97, 221-231 (1999).
5. Machesky, L. M. & Insall, R. H. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr. Biol. 8, 1347-1356 (1998).
6. Miki, H. & Takenawa, T. Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. Biochem. Biophys. Res. Commun. 243, 73-78 (1998).
7. Blanchoin, L. et al. Direct observation of dendritic actin filament networks nucleated by Arp2/3 complex and WASP/Scar proteins. Nature 404, 1007-1011 (2000).
8. Huang, W., Ochs, H. D., Dupont, B. & Vyas, Y. M. The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-κB (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement. J. Immunol. 174, 2602-2611 (2005).
9. Silvin, C. Belisle, B. & Abo, A. A role for Wiskott-Aldrich syndrome protein in T-cell receptor-mediated transcriptional activation independent of actin polymerization. J. Biol. Chem. 276, 21450-21457 (2001).
10. Linardopoulou, E. V. et al. Human subtelomeric WASH genes encode a new subclass of the WASP family. PLoS Genet. 3, 2477-2485 (2007).
11. Campellone, K. G., Webb, N. J., Znameroski, E. A. & Welch, M. D. WHAMM is an Arp2/3 complex activator that binds microtubules and functions in ER to Golgi transport. Cell 134, 148-161 (2008).
12. Sullivan, K. E., Mullen, C. A., Blaese, R. M. & Winkelstein, J. A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125, 876-885 (1994).
13. Dupuis-Girod, S. et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics 111, e622-e627 (2003).
14. Imai, K. et al. Clinical course of patients with WASP gene mutations. Blood 103, 456-464 (2004).
15. Devriendt, K. et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nature Genet. 27, 313-317 (2001).
16. Ancliff, P. J. et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood 108, 2182-2189 (2006).
17. Beel, K. et al. A large kindred with X-linked neutropenia with an I294T mutation of the Wiskott-Aldrich syndrome gene. Br. J. Haematol. 144, 120-126 (2009).
18. Kim, A. S., Kakalis, L. T., Abdul-Manan, N., Liu, G. A. & Rosen, M. K. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 404, 151-158 (2000).
19. Abdul-Manan, N. et al. Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein. Nature 399, 379-383 (1999).
20. Tomasevic, N. et al. Differential regulation of WASP and N-WASP by Cdc42, Rac1, Nck, and PI(4,5)P2. Biochemistry 46, 3494-3502 (2007).
21. Badour, K. et al. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J. Exp. Med. 199, 99-112 (2004).
22. Fukuoka, M. et al. A novel neural Wiskott-Aldrich syndrome protein (N-WASP) binding protein, WISH, induces Arp2/3 complex activation independent of Cdc42. J. Cell Biol. 152, 471-482 (2001).
23. Rohatgi R., Nollau, P., Ho, H. Y., Kirschner, M. W. & Mayer, B. J. Nck and phosphatidylinositol 4, 5-bisphosphate synergistically activate actin polymerization through the N-WASP-Arp2/3 pathway. J. Biol. Chem. 276, 26448-26452 (2001).
24. 2 promotes localized N-WASp-mediated actin polymerization in living cells. Mol. Cell 36, 525-535 (2009).
25. Ho, H. Y. et al. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex. Cell 11 8, 203-216 (2004).
26. Padrick, S. B. et al. Hierarchical regulation of WASP/ WAVE proteins. Mol. Cell 32, 426-438 (2008).
27. Cory, G. O., Garg, R., Cramer, R. & Ridley, A. J. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott-Aldrich Syndrome protein. J. Biol. Chem. 277, 45115-45121 (2002).
28. Park, H. & Cox, D. Cdc42 regulates Fcγ receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich Syndrome protein (WASP) and neural-WASP. Mol. Biol. Cell 20, 4500-11508 (2009).
29. Dovas, A. et al. Regulation of podosome dynamics by WASp phosphorylation: implication in matrix degradation and chemotaxis in macrophages. J. Cell Sci. 122, 3873-3882 (2009).
30. Cammer, M. et al. The mechanism of CSF-1-induced Wiskott-Aldrich syndrome protein activation in vivo: a role for phosphatidylinositol 3-kinase and Cdc42. J. Biol. Chem. 284, 23302-23311 (2009).
31. Ma, T., Samanna, V. & Chellaiah, M. A. Dramatic inhibition of osteoclast sealing ring formation and bone resorption in vitro by a WASP-peptide containing pTyr294 amino acid. J. Mol. Signal. 3, 4 (2008).
32. Blundell, M. P. et al. Phosphorylation of WASp is a key regulator of activity and stability in vivo. Proc. Natl Acad. Sci. USA 106, 15738-15743 (2009).
33. Torres, E. & Rosen, M. K. Contingent phosphorylation/ dephosphorylation provides a mechanism of molecular memory in WASP. Mol. Cell 11, 1215-1227 (2003).
34. Cory, G. O., Cramer, R., Blanchoin, L. & Ridley, A. J. Phosphorylation of the WASP-VCA domain increases its affinity for the Arp2/3 complex and enhances actin polymerization by WASP. Mol. Cell 11, 1229-1239 (2003).
35. Chou, H. C. et al. WIP regulates the stability and localization of WASP to podosomes in migrating dendritic cells. Curr. Biol. 16, 2337-2344 (2006).
36. Konno, A. et al. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T-and B-cell lineages. Blood 103, 676-678 (2004).
37. de la Fuente, M. A. et al. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc. Natl Acad. Sci. USA 104, 926-931 (2007).
38. Ramesh, N., Anton, I. M., Hartwig, J. H. & Geha, R. S. WIP, a protein associated with Wiskott-Aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc. Natl Acad. Sci. USA 94, 14671-14676 (1997).
39. Volkman, B. F., Prehoda, K. E., Scott, J. A., Peterson, F. C. & Lim, W. A. Structure of the N-WASP EVH1 domain-WIP complex: insight into the molecular basis of Wiskott-Aldrich Syndrome. Cell 111, 565-576 (2002).
40. Peterson, F. C. et al. Multiple WASP-interacting protein recognition motifs are required for a functional interaction with N-WASP. J. Biol. Chem. 282, 8446-8453 (2007).
41. Sasahara, Y. et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol. Cell 10, 1269-1281 (2002).
42. Lim, R. P., Misra, A., Wu, Z. & Thanabalu, T. Analysis of conformational changes in WASP using a split YFP. Biochem. Biophys. Res. Commun. 362, 1085-1089 (2007).
43. Imai, K., Nonoyama, S. & Ochs, H. D. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype. Curr. Opin. Allergy Clin. Immunol. 3, 427-436 (2003).
44. Linder, S. et al. Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype. Immunol. Cell Biol. 81, 130-136 (2003).
45. Anton, I. M. & Jones, G. E. WIP: A multifunctional protein involved in actin cytoskeleton regulation. Eur. J. Cell Biol. 85, 295-304 (2006).
46. Anton, I. M. et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity 16, 193-204 (2002).
47. Parolini, O. et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during haematopoietic differentiation. Blood 90, 70-75 (1997).
48. Wengler, G., Gorlin, J. B., Williamson, J. M., Rosen, F. S. & Bing, D. H. Nonrandom inactivation of the X chromosome in early lineage haematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 85, 2471-2477 (1995).
49. Lacout, C. et al. A defect in haematopoietic stem cell migration explains the nonrandom X-chromosome inactivation in carriers of Wiskott-Aldrich syndrome. Blood 102, 1282-1289 (2003).
50. Snapper, S. B. et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity 9, 81-91 (1998).
51. Zhang, J. et al. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes. J. Exp. Med. 190, 1329-1342 (1999).
52. Meyer-Bahlburg, A. et al. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood 11 2, 4158-4169 (2008).
53. Cotta-de-Almeida, V. et al. Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development. Proc. Natl Acad. Sci. USA 104, 15424-15429 (2007).
54. Westerberg, L. S. et al. WASP confers selective advantage for specific haematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. Blood 11 2, 4139-4147 (2008).
55. Davis, B. R. et al. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood 111, 5064-5067 (2008).
56. Davis, B. R. & Candotti, F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol. Res. 44, 127-131 (2009).
57. Ariga, T. et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J. Immunol. 166, 5245-5249 (2001).
58. Wada, T. et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc. Natl Acad. Sci. USA 98, 8697-8702 (2001).
59. Lutskiy, M. I., Sasahara, Y., Kenney, D. M., Rosen, F. S. & Remold-O'Donnell, E. Wiskott-Aldrich syndrome in a female. Blood 100, 2763-2768 (2002).
60. Wada, T. et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J. Clin. Invest. 111, 1389-1397 (2003).
61. Moulding, D. A. et al. Unregulated actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia. J. Exp. Med. 204, 2213-2224 (2007).
62. Park, J. Y. et al. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin. Exp. Immunol. 136, 104-110 (2004).
63. Wada, T., Schurman, S. H., Garabedian, E. K., Yachie, A. & Candotti, F. Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome. Blood 106, 3895-3897 (2005).
64. Gallego, M. D., Santamaria, M., Pena, J. & Molina, I. J. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90, 3089-3097 (1997).
65. Gallego, M. D. et al. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1α. Int. Immunol. 18, 221-232 (2005).
66. Majstoravich, S. et al. Lymphocyte microvilli are dynamic, actin-dependent structures that do not require Wiskott-Aldrich syndrome protein (WASp) for their morphology. Blood 104, 1396-1403 (2004).
67. Badour, K. et al. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity 18, 141-154 (2003).
68. Dupre, L. et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17, 157-166 (2002).
69. Cannon, J. L. & Burkhardt, J. K. Differential roles for Wiskott-Aldrich syndrome protein in immune synapse formation and IL-2 production. J. Immunol. 173, 1658-1662 (2004).
70. + T cells. J. Immunol. 173, 726-730 (2004).
71. + T cells from Wiskott-Aldrich syndrome patients. J. Immunol. 177, 7451-7461 (2006).
72. Morales-Tirado, V. et al. Critical requirement for the Wiskott-Aldrich syndrome protein in Th2 effector function. Blood 23 Dec 2009 (doi:10.1182/blood-2009-07-235754).
73. Zhang, Q. et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361, 2046-2055 (2009).
74. Engelhardt, K. R. et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol. 124, 1289-1302 (2009).
75. Randall, K. L. et al. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nature Immunol. 10, 1283-1291 (2009).
76. Westerberg, L. et al. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood 105, 1144-1152 (2005).
77. Kronenberg, M. & Kinjo, Y. Innate-like recognition of microbes by invariant natural killer T cells. Curr. Opin. Immunol. 21, 391-396 (2009).
78. Berzofsky, J. A. & Terabe, M. The contrasting roles of NKT cells in tumour immunity. Curr. Mol. Med. 9, 667-672 (2009).
79. Astrakhan, A., Ochs, H. D. & Rawlings, D. J. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J. Immunol. 182, 7370-7380 (2009).
80. Locci, M. et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J. Exp. Med. 206, 735-742 (2009).
81. Lorenzi, R., Brickell, P. M., Katz, D. R., Kinnon, C. & Thrasher, A. J. Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis. Blood 95, 2943-2946 (2000).
82. Leverrier, Y. et al. Cutting edge: the Wiskott-Aldrich syndrome protein is required for efficient phagocytosis of apoptotic cells. J. Immunol. 166, 4831-4834 (2001).
83. Tsuboi, S. & Meerloo, J. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages. J. Biol. Chem. 282, 34194-34203 (2007).
84. Burns, S., Thrasher, A. J., Blundell, M. P., Machesky, L. & Jones, G. E. Configuration of human dendritic cell cytoskeleton by Rho GTPases, the WAS protein, and differentiation. Blood 98, 1142-1149 (2001).
85. Linder, S., Nelson, D., Weiss, M. & Aepfelbacher, M. Wiskott-Aldrich syndrome protein regulates podosomes in primary human macrophages. Proc. Natl Acad. Sci. USA 96, 9648-9653 (1999).
86. Zicha, D. et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br. J. Haematol. 101, 659-665 (1998).
87. Badolato, R. et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. J. Immunol. 161, 1026-1033 (1998).
88. de Noronha, S. et al. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein. Blood 105, 1590-1597 (2005).
89. Bouma, G., Burns, S. & Thrasher, A. J. Impaired T-cell priming in vivo resulting from dysfunction of WASp-deficient dendritic cells. Blood 11 0, 4278-4284 (2007).
90. + T cells. J. Immunol. 181, 1135-1142 (2008).
91. Puklin-Faucher, E. & Sheetz, M. P. The mechanical integrin cycle. J. Cell Sci. 122, 179-186 (2009).
92. Burns, S. et al. Maturation of DC is associated with changes in motile characteristics and adherence. Cell. Motil. Cytoskeleton 57, 118-132 (2004).
93. Zhang, H. et al. Impaired integrin-dependent function in Wiskott-Aldrich syndrome protein-deficient murine and human neutrophils. Immunity 25, 285-295 (2006).
94. Orange, J. S. et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and co-localizes with actin to NK cell-activating immunologic synapses. Proc. Natl Acad. Sci. USA 99, 11351-11356 (2002).
95. Gismondi, A. et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood 104, 436-443 (2004).
96. Borg, C. et al. NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 104, 3267-3275 (2004).
97. + regulatory T cells. J. Exp. Med. 204, 381-391 (2007).
98. Humblet-Baron, S. et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J. Clin. Invest. 11 7, 407-418 (2007).
99. + natural regulatory T cells. J. Exp. Med. 204, 369-380 (2007).
100. Adriani, M. et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin. Immunol. 124, 41-48 (2007).
101. Ozsahin, H. et al. Long-term outcome following haematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 111, 439-445 (2008).
102. - mice correlate with evidence of increased in vivo platelet consumption. Exp. Haematol. 37, 1353-1363 (2009).